Most people experiencing injection site reactions can successfully continue their dosing protocols by: Optimizing injection technique: Aggressive dilution (3mL+), strict rotation (1-2 cm spacing), slow injection, room temperature peptides, 4mm needles Pre-treating reactive injections: Benadryl cream applied one minute before injection Keeping KPV as insurance: 500mcg immediately after reactive injections Addressing root causes: Healing gut, supporting DAO levels, optimizing estradiol readings, correcting nutrient deficiencies Taking methodical approach to stacking: Testing individual peptides before combining, building tolerance progressively Research across thousands of patients confirms that treatment discontinuation due to injection site reactions is extremely rare
This is more noticeable in the first few weeks and usually indicates the peptide is working
Some studies have even shown that the opposite could be the case
Indeed, GIP administration reduces cell apoptosis and enhances cell mass in animal models [32]
This differs from the profound exhaustion that might signal thyroid complications or severe hypoglycemia
US obesity trends and the rise of GLP-1 drugs Obesity in the US keeps rising, contributing to health risks such as diabetes and heart disease